Foley Hoag Panelists to Discuss Off-Label Marketing and Price Valuation at 2014 BIO International

Annual convention represents over 1,100 biotech companies, academic institutions and state biotech centers.

June 17, 2014

Partners from Foley Hoag LLP will discuss pricing and regulatory issues affecting the biotechnology and pharmaceutical industries at the 2014 BIO International Convention from June 23-27 at the San Diego Convention Center in San Diego, CA.

The panel discussions will include:

Comparative Effectiveness, Truthful Promotion and the Caronia Case Rulings on Off-Label Marketing.
Partner Paul Kim will moderate this panel will consider such questions in light of United States v. Caronia, a case in which sales representatives’ conviction for marketing a drug for off-label use was recently overturned. The panel will be held June 24 from 10:15-11:30 a.m.

Is Value in the Eye of the Beholder?
Partner Hemmie Chang  will moderate this panel that offers insight into what to expect and how to weight valuation questions for both emerging companies and larger partners. The panel will be held June 24 from 3-4 p.m.

Foley Hoag, which is a sponsor of the 2014 BIO International Convention, also is a co-sponsor of the Business Development session track with KPMG. Attendees at the BIO International Convention, the largest global event for the biotechnology industry, may visit the Foley Hoag booth (Booth #4403) to get the latest information on the firm’s life sciences services.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and investment management fields, and in cross-border disputes. Our professionals  possess the skills  and experience to provide exceptional senior level service to clients ranging from startups to multinational companies to sovereign states. For more information, visit or follow @FoleyHoag on Twitter.